Supernus Pharm (SUPN) Posts Q2 Loss of 89c/Share
Supernus Pharm (NASDAQ: SUPN) reported Q2 EPS of ($0.89), which ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
